273 related articles for article (PubMed ID: 18483368)
1. Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
Duncan TJ; Al-Attar A; Rolland P; Scott IV; Deen S; Liu DT; Spendlove I; Durrant LG
Clin Cancer Res; 2008 May; 14(10):3030-5. PubMed ID: 18483368
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer.
Duncan TJ; Al-Attar A; Rolland P; Harper S; Spendlove I; Durrant LG
Int J Gynecol Pathol; 2010 Jan; 29(1):8-18. PubMed ID: 19952944
[TBL] [Abstract][Full Text] [Related]
3. Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer.
Duncan TJ; Rolland P; Deen S; Scott IV; Liu DT; Spendlove I; Durrant LG
Clin Cancer Res; 2007 Jul; 13(14):4139-45. PubMed ID: 17634541
[TBL] [Abstract][Full Text] [Related]
4. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
6. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
Rolland P; Deen S; Scott I; Durrant L; Spendlove I
Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
[TBL] [Abstract][Full Text] [Related]
9. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
Qi SY
Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
[TBL] [Abstract][Full Text] [Related]
11. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
Shi L; Chen XM; Wang L; Zhang L; Chen Z
Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
Oehler MK; Caffier H
Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
Hefler LA; Mustea A; Könsgen D; Concin N; Tanner B; Strick R; Heinze G; Grimm C; Schuster E; Tempfer C; Reinthaller A; Zeillinger R
Clin Cancer Res; 2007 Feb; 13(3):898-901. PubMed ID: 17289883
[TBL] [Abstract][Full Text] [Related]
15. Angiostatin expression in ovarian cancer.
Yabushita H; Noguchi M; Obayashi Y; Kishida T; Noguchi Y; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(5):1225-30. PubMed ID: 12883685
[TBL] [Abstract][Full Text] [Related]
16. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R
Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients.
Kassim SK; El-Salahy EM; Fayed ST; Helal SA; Helal T; Azzam Eel-D; Khalifa A
Clin Biochem; 2004 May; 37(5):363-9. PubMed ID: 15087251
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas.
Ueda M; Hung YC; Terai Y; Kanda K; Kanemura M; Futakuchi H; Yamaguchi H; Akise D; Yasuda M; Ueki M
Clin Cancer Res; 2005 May; 11(9):3225-32. PubMed ID: 15867217
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
Kamat AA; Merritt WM; Coffey D; Lin YG; Patel PR; Broaddus R; Nugent E; Han LY; Landen CN; Spannuth WA; Lu C; Coleman RL; Gershenson DM; Sood AK
Clin Cancer Res; 2007 Dec; 13(24):7487-95. PubMed ID: 18094433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
